The Hedge Funds Behind the Biopharma IPO Bonanza

Perceptive, RA Capital and RTW are among hedge fund firms with stakes in biopharma companies preparing to go public.

Michael Nagle/Bloomberg

Michael Nagle/Bloomberg

The market for initial public offerings has picked up where it left off in 2020. Red hot.

And many hedge funds are eager to cash in, especially in the booming biopharma and health-care-related sectors.

In the past week or so, at least five companies whose major shareholders include at least eight firms most associated with their hedge funds have filed plans to go public.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.